Filter
925
Text search:
adverse
drug
reactions
Featured
Recommendations
123
New Publications
257
Language
Document type
No document type
573
Guidelines
168
Studies & Reports
87
Manuals
52
Strategic & Response Plan
15
Fact sheets
11
Training Material
10
Brochures
3
Situation Updates
3
Resource Platforms
1
Infographics
1
Countries / Regions
India
70
Kenya
28
South Africa
28
Ethiopia
27
Tanzania
23
Western and Central Europe
21
Uganda
20
Global
20
Nigeria
18
Zambia
17
Malawi
16
Nepal
15
Ghana
14
Philippines
10
Bangladesh
10
Namibia
10
Latin America and the Carribbean
10
Eastern Europe
10
Zimbabwe
9
Cambodia
9
Sierra Leone
8
Liberia
8
Myanmar / Burma
8
Africa
7
Rwanda
6
Botswana
6
Eswatini/ Swaziland
5
South–East Asia Region
5
USA
4
South Sudan
3
Germany
3
Syria
3
Indonesia
3
Brazil
3
Ukraine
3
Sri Lanka
3
Western Pacific Region
3
Congo, Democratic Republic of
2
Haiti
2
Thailand
2
Argentina
2
Colombia
2
Bolivia
2
Lesotho
2
Asia
2
Timor Leste/ East Timor
2
Russia
2
Senegal
1
Mali
1
Cameroon
1
Iraq
1
Lebanon
1
Chad
1
Gambia
1
China
1
Ireland
1
Mozambique
1
Benin
1
Angola
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Solomon Islands
1
Bhutan
1
North Korea
1
Laos
1
Australia
1
Georgia
1
Vietnam
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
359
Clinical Guidelines
133
Public Health
45
Women & Child Health
26
Key Resources
18
Capacity Building
13
Pharmacy & Technologies
12
Toolboxes
TB
135
Mental Health
79
HIV
78
Pharmacy
66
NTDs
50
COVID-19
34
AMR
27
Caregiver
18
Ebola & Marburg
17
Malaria
16
NCDs
14
Refugee
10
Polio
8
Conflict
8
Rapid Response
7
Specific Hazards
5
Natural Hazards
4
Planetary Health
4
Disability
3
Cholera
3
Zika
3
Global Health Education
3
2.0 Rapid Response
3
Health Financing Toolbox
1
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar
...
National Medicines Policy 2015
recommended
National Tuberculosis Programme and Senior Paediatricians
This guideline was first developed in 2007 but further updated in 2012 and 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to T ...
This guideline was first developed in 2007 but further updated in 2012 and 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to T ...
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART
...
• diagnosis of HIV
• update on the initiation of ART
...
Sub-Saharan African Journal of Medicine: Year : 2014 | Volume : 1 | Issue : 1 | Page : 1-14
This joint publication by UNAIDS and WHO emphasizes the importance of integrating HIV prevention, testing, treatment and care and mental health services for people living with HIV. It provides a compilation of tools, best practices, recommendations and guidelines that facilitate the integration of i
...
Accessed November, 2017
An Indicator-based Approach - This manual presents an indicator-based approach for rapidly assessing pharmaceutical management systems and programs. The manual contains a set of 46 indicators of performance, grouped under eight topics of pharmaceutical management, with each topic being covered by a
...
Accessed November 2017
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
guidance for health managers, health workers, and activists
